Press Releases

  • 2017-08-16
    Julphar, the largest generic pharmaceutical manufacturer in Middle East and North Africa (MENA), announced sales revenue of AED 639 million in the first semester of the year 2017. The company posted a net profit of AED 64 million. Julphar’s Chairman,…
  • 2017-08-10
    The local intravenous fluids manufacturer Gulf Inject announced it has signed a distribution agreement with the UAE-based healthcare leader Zulekha   Gulf Inject, a Julphar company - the region’s leading pharmaceutical manufacturer, has announced…
  • 2017-06-08
    The Emirati pharmaceutical company Julphar Gulf Pharmaceutical Industries, one of the key players in the region, has launched a new drug – Dandasha – in the UAE market to treat erectile dysfunction (ED) in adult men.   Marketed in tablets…
  • 2017-05-25
    During the meeting held on May 18th 2017, Julphar Gulf Pharmaceutical Industries’ Board of Directors released the company’s quarterly results and business achievements for the first three months of the year.   The Board discussed the…